Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.05 -0.08 (-1.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Return on Sales [ROS] (2015 - 2024)

Updated

Corbus Pharmaceuticals Holdings (CRBP) recorded Return on Sales [ROS] of -45961.32% in Q2 2022, down 33731.31 percentage points from -12230.01% a year earlier and down 24971.17 percentage points from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Return on Sales [ROS] (2015 - 2024) Analysis & Trends

For FY2021, Corbus Pharmaceuticals Holdings reported Return on Sales [ROS] of -6350.09%, down 3230.88 percentage points from FY2020.

  • Annual Return on Sales [ROS] has a four-year change of -5015.65 percentage points (FY2017 to FY2021).
  • Across earlier years, Return on Sales [ROS] came in at -3119.20% in FY2020 (-2905.88 pp), -213.33% in FY2019 (+963.45 pp), -1176.78% in FY2018 (+157.65 pp) and -1334.43% in FY2017.
  • The Q2 2022 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q2 2015.
  • On a year-over-year basis, Return on Sales [ROS] has declined for four consecutive quarters, with an average year-over-year change of -8814.74 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1457.72 percentage points in Q2 2019, against a drop of 33731.31 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -20990.16% (Q1 2022), -6350.09% (Q4 2021) and -14257.07% (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Corbus Pharmaceuticals Holdings 49.84 Mn -466.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -1,304.04%
Jun 30, 2024 -1,212.80%
Sep 30, 2023 -4,357.53%
Jun 30, 2023 -3,529.24%
Jun 30, 2022 -45,961.32%
Mar 31, 2022 -20,990.16%
Dec 31, 2021 -6,350.09%
Sep 30, 2021 -14,257.07%
Jun 30, 2021 -12,230.01%
Mar 31, 2021 -2,379.38%
Dec 31, 2020 -3,161.99%
Sep 30, 2020 -2,760.72%
Jun 30, 2020 -13,319.09%
Mar 31, 2020 -1,696.04%
Dec 31, 2019 -1,056.54%
Sep 30, 2019 -969.07%
Jun 30, 2019 5.86%
Mar 31, 2019 -1,406.53%
Dec 31, 2018 -912.72%
Sep 30, 2018 -1,365.69%
API Access

Corbus Pharmaceuticals Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRBP&period=max&api_key=YOUR_API_KEY